Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and Health-related Quality of Life After Three Months of Treatment in Patients With Asthma: Trimaximize - A Real-world View From Germany, United Kingdom, Austria and Denmark

被引：0
|
作者：
Gessner, C. [1 ]
Akyildiz, B. [2 ]
Pohl, W. [3 ]
Nachtigall, D. [2 ]
Russell, R. [4 ]
Bogoevska, V. [2 ]
Ulrik, C. S. [5 ]
Watz, H. [6 ]
机构：
[1] Specialized Practice Pulm Med, Leipzig, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Hietzing Hosp, Karl Landsteiner Inst Clin & Expt Pneumol, Vienna, Austria
[4] Univ Oxford, Oxford, England
[5] Hvidovre Univ Hosp, Dept Pulm Med, Hvidovre, Denmark
[6] LungenClin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6649
引用
收藏
页数：2
相关论文
共 30 条
  • [21] Change in lung function after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Wendt, A.
    Licht, B.
    Criee, C.
    PNEUMOLOGIE, 2023, 77 : S36 - S36
  • [22] Improvement of health-related quality of life after 3 months of treatment with extrafine singleinhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Martini, M.
    Meyer-Duderstaedt, T.
    Koczulla, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Exacerbation reduction and improved quality of life in asthma with extrafine formulation single-inhaler triple therapy (efSITT): six-month results of the TriMaximize Study
    Trinkmann, Frederik
    Bogoevska, Valentina
    Nachtigall, Detlef
    Russell, Richard
    Ulrik, Charlotte Suppli
    Pohl, Wolfgang
    Plaza, Vicente
    Bourdin, Arnaud
    Fritz, Celina
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] TriOptimize III: Extrafine single inhaler Triple Therapy in COPD improves health-related quality of life in a real-world setting in Germany
    Hoevelmann, R.
    Georges, G.
    Javan, Bahari S.
    Melchior, K.
    Criee, C. P.
    Gessner, C.
    PNEUMOLOGIE, 2020, 74 : S43 - S43
  • [25] Treatment with extrafine formulation single-inhaler triple therapy improves disease control and adherence in patients with asthma - a 3-month interim analysis from the TriMaximize UK study
    Richards, J.
    Rangwani, N.
    Russell, R.
    THORAX, 2023, 78 (SUPPL_4) : A83 - A84
  • [26] TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting
    Gessner, Christian
    Javan, Sanaz Bahari
    Hoevelmann, Raimund
    Georges, George
    Melchior, Kai
    Criee, Carl-Peter
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] Trioptimize IV: Improvement of Health-Related Quality of Life in Patients with COPD Treated with Extrafine Single Inhaler Triple Therapy in a Real-World Setting
    Gessner, C.
    Criee, C.
    Georges, G.
    Javan, S. Bahari
    Melchior, K.
    Hoevelmann, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Health-related Quality of Life and Productivity Among a Real-World Cohort of Severe Asthma Patients in the United States
    Soong, Weily
    Chipps, Bradley
    Trevor, Jennifer
    Carr, Warner
    O'Quinn, Sean
    Trudo, Frank
    Ambrose, Chris
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB204 - AB204
  • [29] EFFECT OF SINGLE-INHALER EXTRAFINE BECLOMETASONE/FORMOTEROL/GLYCOPYRRONIUM PMDI (BDP/FF/GB) COMPARED WITH TWO-INHALER FLUTICASONE FUROATE/VILANTEROL DPI plus TIOTROPIUM DPI (FLF/VIL plus TIO) TRIPLE THERAPY ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH COPD: THE TRISTAR STUDY
    Kots, M.
    Georges, G.
    Guasconi, A.
    Vogelmeier, C.
    THORAX, 2021, 76 : A20 - A20
  • [30] The Influence of the new CFTR Modulator Triple Therapy (Elexacaftor/Tezacaftor/Ivacaftor) after three Months of Treatment on Lung Function, physical Exertion and health-related Quality of Life in Patients with Cystic Fibrosis
    Wollsching-Strobel, M.
    Dieninghoff, D.
    Emrich, F. L.
    Kroppen, D.
    Majorski, D.
    Mathes, T.
    Magnet, S. F.
    Schwarz, S.
    Windisch, W.
    PNEUMOLOGIE, 2022, 76 : S84 - S85
123